Hydrochlorothiazide Capsule
Product Images NDC 0615-8344

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 0615-8344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Hydrochlorothiazide Caps 12 5mg 8344 1)

Figure-01 (Hydrochlorothiazide Caps 12 5mg   8344 1)
Chemical structure of Hydrochlorothiazide showing the arrangement of its molecular components, including sulfur, nitrogen, chlorine, and oxygen atoms in the bicyclic thiazide ring system.*
FDA Label Image

Hydrochlorothiazide Caps 12.5mg Bingo Card Label (Hydrochlorothiazide Caps 12 5mg 8344 2)

Hydrochlorothiazide Caps 12.5mg Bingo Card Label (Hydrochlorothiazide Caps 12 5mg   8344 2)
Hydrochlorothiazide Caps USP 12.5 mg capsule packaging label showing product name, strength, and dosage form. The label includes barcodes, lot number 8344, and storage instructions to keep at 20°-25°C. Manufactured by ScieGen and packaged by Vangard Labs, Glasgow, KY, the label emphasizes institutional use only and protection from light and moisture. The package quantity is 30 capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.